These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

220 related items for PubMed ID: 6487685

  • 1. [Diabetogenic action of alloxan in short-term termination of the blood supply to the pancreas and spleen].
    Ul'ianov AM, Tarasov IuA.
    Nauchnye Doki Vyss Shkoly Biol Nauki; 1984; (8):48-51. PubMed ID: 6487685
    [Abstract] [Full Text] [Related]

  • 2. Diabetogenic action of alloxan following temporary interruption of arterial blood flow to pancreas in rats.
    Bilic N, Felber JP.
    Diabetes; 1970 Feb; 19(2):81-4. PubMed ID: 4905638
    [No Abstract] [Full Text] [Related]

  • 3. [Animal sensitivity to the diabetogenic action of alloxan during cold adaptation].
    Shorin IuP, Seliatitskaia VG, Nepomniashchikh GI, Pal'chikova NA, Khodova RR.
    Biull Eksp Biol Med; 1984 Aug; 98(8):240-2. PubMed ID: 6466864
    [Abstract] [Full Text] [Related]

  • 4. Hepatic and pancreatic effects of polyenoylphosphatidylcholine in rats with alloxan-induced diabetes.
    Buko V, Lukivskaya O, Nikitin V, Tarasov Y, Zavodnik L, Borodinsky A, Gorenshtein B, Janz B, Gundermann KJ, Schumacher R.
    Cell Biochem Funct; 1996 Jun; 14(2):131-7. PubMed ID: 8640953
    [Abstract] [Full Text] [Related]

  • 5. [The pancreas as a source of natural diabetogenic factor in alloxan diabetes].
    Kudriashov BA, Tarasov IuA, Ul'ianov AM.
    Patol Fiziol Eksp Ter; 1991 Jun; (2):46-7. PubMed ID: 1881712
    [Abstract] [Full Text] [Related]

  • 6. [Experimental analysis of the pathophysiological significance of the "diabetogenic factor" present in the blood of animals with alloxan diabetes].
    Baskakova GM, Kudriashov BA, Pytel' IuA.
    Probl Endokrinol (Mosk); 1981 Jun; 27(4):42-5. PubMed ID: 7027248
    [Abstract] [Full Text] [Related]

  • 7. Effects of berberine on diabetes induced by alloxan and a high-fat/high-cholesterol diet in rats.
    Tang LQ, Wei W, Chen LM, Liu S.
    J Ethnopharmacol; 2006 Nov 03; 108(1):109-15. PubMed ID: 16759828
    [Abstract] [Full Text] [Related]

  • 8. Reduction in the diabetogenic effect of alloxan in mice by treatment with the antineoplastic agent ICRF-187.
    El-Hage AN, Herman EH, Ferrans VJ.
    Res Commun Chem Pathol Pharmacol; 1981 Sep 03; 33(3):509-23. PubMed ID: 7036302
    [Abstract] [Full Text] [Related]

  • 9. [Functional changes in the state of the insular system of animals after intravenous administration of diabetogenic factor].
    Kudriashov BA, Ul'ianov AM, Liapina LA.
    Vopr Med Khim; 1986 Sep 03; 32(5):57-9. PubMed ID: 3535246
    [Abstract] [Full Text] [Related]

  • 10. The antidiabetic effects of cysteinyl metformin, a newly synthesized agent, in alloxan- and streptozocin-induced diabetic rats.
    Liu Z, Li J, Zeng Z, Liu M, Wang M.
    Chem Biol Interact; 2008 May 09; 173(1):68-75. PubMed ID: 18377884
    [Abstract] [Full Text] [Related]

  • 11. [Morphometric evaluation of the intensity of blood flow in the islands of Langerhans and of the effectiveness of controlled revascularization of the pancreas under experimental conditions].
    Khananaev LI, Mikhaĭliuk IA.
    Arkh Anat Gistol Embriol; 1978 Apr 09; 74(4):97-100. PubMed ID: 354601
    [Abstract] [Full Text] [Related]

  • 12. [Prophylactic effect of vitamin A, neutralizing the development of experimental insulin-dependent diabetes in animals].
    Kudriashov BA, Ul'ianov AM, Tarasov IuA.
    Vopr Med Khim; 1993 Apr 09; 39(1):20-2. PubMed ID: 8498064
    [Abstract] [Full Text] [Related]

  • 13. [A model of diabetes mellitus in dogs: combination of pancreas resection with intra-arterial administration of alloxan].
    Agaev BA, Velikhanova DM, Gadzhiev AN.
    Probl Endokrinol (Mosk); 1992 Apr 09; 38(3):46-8. PubMed ID: 1513794
    [Abstract] [Full Text] [Related]

  • 14. The status of magnesium in rabbits with experimentally-induced diabetes mellitus.
    Bhimji S, Godin DV, McNeill JH.
    Horm Metab Res; 1986 Nov 09; 18(11):734-8. PubMed ID: 3539735
    [Abstract] [Full Text] [Related]

  • 15. L-arginine and polyamine administration protect beta-cells against alloxan diabetogenic effect in Sprague-Dawley rats.
    Méndez JD, Hernández Rde H.
    Biomed Pharmacother; 2005 Jul 09; 59(6):283-9. PubMed ID: 15996850
    [Abstract] [Full Text] [Related]

  • 16. [Role of the pancreas in the appearance of the diabetogenic factor during the development of alloxan diabetes].
    Kudriashov BA, Tarasov IuA, Ul'ianov AM.
    Patol Fiziol Eksp Ter; 1989 Jul 09; (3):75-9. PubMed ID: 2797907
    [Abstract] [Full Text] [Related]

  • 17. [Antianemic effect of reamberin in rats with acute alloxan-induced diabetes].
    Volchegorskiĭ IA, Tishevskaia NV, Dement'eva EV.
    Eksp Klin Farmakol; 2008 Jul 09; 71(6):23-7. PubMed ID: 19140511
    [Abstract] [Full Text] [Related]

  • 18. [Intensification of the diabetogenic effect of alloxan by protamine sulfate].
    Kudriashov BA, Ul'ianov AM, Tarasov IuA.
    Vopr Med Khim; 1989 Jul 09; 35(4):128-31. PubMed ID: 2815670
    [Abstract] [Full Text] [Related]

  • 19. Study on the antidiabetic mechanism of a shark liver peptide, S-8300, in alloxan-induced diabetes.
    Huang F, Wu W.
    J Pharm Pharmacol; 2009 Jun 09; 61(6):789-94. PubMed ID: 19505370
    [Abstract] [Full Text] [Related]

  • 20. Tilapia islet grafts are highly alloxan-resistant.
    Xu BY, Morrison CM, Yang H, Wright JR.
    Gen Comp Endocrinol; 2004 Jun 09; 137(2):132-40. PubMed ID: 15158125
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.